BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18219159)

  • 1. Preprocedural statin administration can reduce thrombotic reaction after stent implantation.
    Nishino M; Hoshida S; Kato H; Egami Y; Shutta R; Yamaguchi H; Tanaka K; Tanouchi J; Hori M; Yamada Y
    Circ J; 2008 Feb; 72(2):232-7. PubMed ID: 18219159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
    Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of inflammatory biomarkers after stent implantation].
    Niccoli G; Montone RA; Ferrante G; Minelli S; Crea F
    G Ital Cardiol (Rome); 2011 Oct; 12(10):635-44. PubMed ID: 21947106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein.
    Jeong HC; Ahn Y; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC;
    Int J Cardiol; 2013 Sep; 167(5):1848-53. PubMed ID: 22592028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of inflammatory biomarkers in risk assessment after stent implantation.
    Niccoli G; Montone RA; Ferrante G; Crea F
    J Am Coll Cardiol; 2010 Nov; 56(22):1783-93. PubMed ID: 21087705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do statins have a role in reduction/prevention of post-PCI restenosis?
    Prasad K
    Cardiovasc Ther; 2013 Feb; 31(1):12-26. PubMed ID: 21967674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
    Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
    Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.
    Yagi S; Kondo D; Ise T; Fukuda D; Yamaguchi K; Wakatsuki T; Kawabata Y; Ito H; Saijo Y; Seno H; Sutou K; Ueno R; Todoroki T; Kusunose K; Matsuura T; Tobiume T; Yamada H; Soeki T; Shimabukuro M; Aihara KI; Akaike M; Sata M
    J Atheroscler Thromb; 2019 Mar; 26(3):272-281. PubMed ID: 30135329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation.
    Walter DH; Fichtlscherer S; Britten MB; Rosin P; Auch-Schwelk W; Schächinger V; Zeiher AM
    J Am Coll Cardiol; 2001 Dec; 38(7):2006-12. PubMed ID: 11738308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction.
    Iwata A; Miura S; Shirai K; Kawamura A; Tomita S; Matsuo Y; Zhang B; Nishikawa H; Kumagai K; Matsuo K; Saku K
    Intern Med; 2006; 45(15):885-90. PubMed ID: 16946569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
    Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
    J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis.
    Nishikawa H; Miura S; Shimomura H; Tsujita K; Okamura K; Zhang B; Iwata A; Shirai K; Matsuo K; Arai H; Saku K
    J Cardiol; 2005 Mar; 45(3):107-13. PubMed ID: 15801275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins.
    Hoshida S; Nishino M; Takeda T; Tanouchi J; Yamada Y; Hori M
    Atherosclerosis; 2004 Apr; 173(2):285-90. PubMed ID: 15064103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.